Novartis sales and marketing update

NVS's Novartis Oncology division (East Hanover, N.J.) began shipping for U.S. sale its Gleevec imatinib mesylate ( STI-571), an oral small molecule Bcr-Abl kinase inhibitor. The compound received FDA...